NEUPOGEN Side Effects

6698562-7 | Blood Stem Cell Harvest Failure
on Apr 19, 2010 Male patient from GERMANY , weighting 196.2 lb, was diagnosed with peripheral blood stem cell apheresis and was treated with Neupogen (View Usage). Patient experienced the following unwanted or unexpected effects: blood stem cell harvest failure. Neupogen dosage: . During the same period patient was treated with PARACETAMOL (View Paracetamol Review and Paracetamol Label ). Patient was hospitalized.

6698466-X | Blood Stem Cell Harvest Failure
Patient was taking Neupogen (View Usage). Patient had the following side effects: blood stem cell harvest failure on Apr 19, 2010 from GERMANY Additional patient health information: Female patient , weighting 145.5 lb, was diagnosed with peripheral blood stem cell apheresis and. Neupogen dosage: . During the same period patient was treated with PARACETAMOL (View Paracetamol Review and Paracetamol Label ). Patient was hospitalized.

6698462-2 | Blood Stem Cell Harvest Failure
Adverse event was reported on Apr 19, 2010 by a Female patient taking Neupogen (View Usage) (Dosage: ) . Location: GERMANY , weighting 123.5 lb, After Neupogen was administered, patient had the following side effects: blood stem cell harvest failure. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ).

6697517-6 | Headache, Vision Blurred
on Apr 08, 2010 Female patient from THAILAND , 37 years of age, was treated with Neupogen (View Usage). Patient experienced the following unwanted or unexpected effects: headache (What is headache?), vision blurred. Neupogen dosage: . During the same period patient was treated with ELTROXIN (View Eltroxin Review and Eltroxin Label ).


6671565-4 | Bone Marrow Necrosis, Pain
on Apr 01, 2010 Male patient from AUSTRALIA , weighting 264.6 lb, was diagnosed with neutropenia and was treated with Neupogen (View Usage). Patient had the following side effects: bone marrow necrosis, pain (What is pain?). Neupogen dosage: . During the same period patient was treated with PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), THYROXIN (View Thyroxin Review and Thyroxin Label ), COLOXYL WITH SENNA (View Coloxyl With Senna Review and Coloxyl With Senna Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ). Patient was hospitalized.

6654178-X | International Normalised Ratio Abnormal, Thrombophlebitis
Patient was taking Neupogen (View Usage). After Neupogen was administered, patient had the following side effects: international normalised ratio abnormal, thrombophlebitis on Mar 19, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 118.2 lb, . Neupogen dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), EMEND (View Emend Review and Emend Label ), TAXOL (View Taxol Review and Taxol Label ), COUMADIN (View Coumadin Review and Coumadin Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ZOFRAN (View Zofran Review and Zofran Label ).

6651272-4 | Neutrophil Count Decreased
Adverse event was reported on Dec 15, 2009 by a Female patient taking Neupogen (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 119.0 lb, Patient experienced the following unwanted or unexpected effects: neutrophil count decreased. During the same period patient was treated with NEULASTA (View Neulasta Review and Neulasta Label ), FLUDARABINE PHOSPHATE (View Fludarabine Phosphate Review and Fludarabine Phosphate Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ).

6651239-6 | Autoimmune Thyroiditis, Blood Stem Cell Harvest Failure, Diarrhoea, Leukopenia, Liver Function Test Abnormal, Performance Status Decreased, Weight Decreased
on Mar 17, 2010 Male patient from GERMANY , weighting 143.3 lb, was diagnosed with blood stem cell harvest and was treated with Neupogen (View Usage). Patient had the following side effects: autoimmune thyroiditis, blood stem cell harvest failure, diarrhoea, leukopenia, liver function test abnormal, performance status decreased, weight decreased. Neupogen dosage: . Patient was hospitalized.

6646757-0 | Blood Stem Cell Harvest Failure
on Mar 12, 2010 Male patient from GERMANY , weighting 141.1 lb, was diagnosed with peripheral blood stem cell apheresis and was treated with Neupogen (View Usage). After Neupogen was administered, patient had the following side effects: blood stem cell harvest failure. Neupogen dosage: . During the same period patient was treated with PARACETAMOL (View Paracetamol Review and Paracetamol Label ). Patient was hospitalized.

6646755-7 | Blood Stem Cell Harvest Failure
Patient was taking Neupogen (View Usage). Patient experienced the following unwanted or unexpected effects: blood stem cell harvest failure on Mar 12, 2010 from GERMANY Additional patient health information: Male patient , weighting 196.2 lb, was diagnosed with peripheral blood stem cell apheresis and. Neupogen dosage: . During the same period patient was treated with PARACETAMOL (View Paracetamol Review and Paracetamol Label ). Patient was hospitalized.

6646746-6 | Blood Stem Cell Harvest Failure
Adverse event was reported on Mar 12, 2010 by a Female patient taking Neupogen (View Usage) (Dosage: ) was diagnosed with peripheral blood stem cell apheresis and. Location: GERMANY , weighting 145.5 lb, Patient had the following side effects: blood stem cell harvest failure. During the same period patient was treated with PARACETAMOL (View Paracetamol Review and Paracetamol Label ). Patient was hospitalized.

6641512-X | Blood Stem Cell Harvest Failure
on Mar 12, 2010 Female patient from GERMANY , weighting 123.5 lb, was treated with Neupogen (View Usage). After Neupogen was administered, patient had the following side effects: blood stem cell harvest failure. Neupogen dosage: . During the same period patient was treated with PARACETAMOL (View Paracetamol Review and Paracetamol Label ).

6633656-3 | Bone Marrow Necrosis, Pain
on Mar 05, 2010 Male patient from AUSTRALIA , weighting 229.3 lb, was diagnosed with neutropenia and was treated with Neupogen (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow necrosis, pain (What is pain?). Neupogen dosage: . During the same period patient was treated with PERINDOPRIL (View Perindopril Review and Perindopril Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), THYROXIN (View Thyroxin Review and Thyroxin Label ), COLOXYL WITH SENNA (View Coloxyl With Senna Review and Coloxyl With Senna Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ). Patient was hospitalized.

6633385-6 | Acute Respiratory Distress Syndrome, Cardiac Failure, Hepatocellular Injury, Peritonitis, Pneumothorax, Respiratory Failure, Thrombocytopenia
Patient was taking Neupogen (View Usage). Patient had the following side effects: acute respiratory distress syndrome, cardiac failure, hepatocellular injury, peritonitis, pneumothorax, respiratory failure, thrombocytopenia on Feb 25, 2010 from SWITZERLAND Additional patient health information: Male patient , child 7 years of age, . Neupogen dosage: . During the same period patient was treated with ROCEPHIN (View Rocephin Review and Rocephin Label ), BACTRIM (View Bactrim Review and Bactrim Label ), LIQUEMINE (View Liquemine Review and Liquemine Label ), CYTOSAR U (View Cytosar-u Review and Cytosar-u Label ), SINTROM (View Sintrom Review and Sintrom Label ), GARAMYCIN (View Garamycin Review and Garamycin Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ZOFRAN (View Zofran Review and Zofran Label ). Patient was hospitalized.

6626640-7 | Granulocytopenia
Adverse event was reported on Mar 04, 2010 by a Female patient taking Neupogen (View Usage) (Dosage: ) . Location: GERMANY , 29 years of age, After Neupogen was administered, patient had the following side effects: granulocytopenia.

6621592-8 | Conjunctivitis, Pyrexia, Rash Pruritic
on Feb 26, 2010 Male patient from UNITED STATES , weighting 159.2 lb, was treated with Neupogen (View Usage). Patient experienced the following unwanted or unexpected effects: conjunctivitis, pyrexia, rash pruritic. Neupogen dosage: . During the same period patient was treated with PRIMAXIN (View Primaxin Review and Primaxin Label ), LEUKINE (View Leukine Review and Leukine Label ), BACTRIM (View Bactrim Review and Bactrim Label ), CLADRIBINE (View Cladribine Review and Cladribine Label ), FORTAZ (View Fortaz Review and Fortaz Label ).

6616849-0 | Bone Pain, Dizziness, Neutrophil Count Decreased, Tinnitus, White Blood Cell Count Decreased
on Jan 06, 2010 Male patient from UNITED STATES , 60 years of age, was diagnosed with neutropenia and was treated with Neupogen (View Usage). Patient had the following side effects: bone pain, dizziness (What is dizziness?), neutrophil count decreased, tinnitus (What is tinnitus?), white blood cell count decreased. Neupogen dosage: . During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ), COPEGUS (View Copegus Review and Copegus Label ).

6614039-9 | Dyspnoea, Metabolic Acidosis, Multi-organ Failure, Pericarditis, Renal Impairment, Septic Shock
Patient was taking Neupogen (View Usage). After Neupogen was administered, patient had the following side effects: dyspnoea, metabolic acidosis, multi-organ failure, pericarditis, renal impairment, septic shock on Feb 22, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 43 years of age, weighting 194.0 lb, was diagnosed with acute myeloid leukaemia and. Neupogen dosage: . During the same period patient was treated with ARA C (View Ara-c Review and Ara-c Label ), CLOFARABINE (View Clofarabine Review and Clofarabine Label ), FLUDARA (View Fludara Review and Fludara Label ), MYLOTARG (View Mylotarg Review and Mylotarg Label ), IDARUBICIN HCL (View Idarubicin Hcl Review and Idarubicin Hcl Label ), AMBISOME (View Ambisome Review and Ambisome Label ), RASBURICASE (View Rasburicase Review and Rasburicase Label ), VALTREX (View Valtrex Review and Valtrex Label ). Patient was hospitalized.

6605192-1 | Granulocytopenia
Adverse event was reported on Feb 18, 2010 by a Female patient taking Neupogen (View Usage) (Dosage: ) . Location: GERMANY , 29 years of age, Patient experienced the following unwanted or unexpected effects: granulocytopenia.

6597804-6 | Pyrexia, Rash Pruritic
on Feb 16, 2010 Male patient from UNITED STATES , 62 years of age, was treated with Neupogen (View Usage). Patient had the following side effects: pyrexia, rash pruritic. Neupogen dosage: . During the same period patient was treated with LEUKINE (View Leukine Review and Leukine Label ), BACTRIM (View Bactrim Review and Bactrim Label ).

6597798-3 | Neutropenia, Pneumonia, Pyrexia
on Feb 16, 2010 Male patient from UNITED STATES , 75 years of age, was diagnosed with myelodysplastic syndrome and was treated with Neupogen (View Usage). After Neupogen was administered, patient had the following side effects: neutropenia, pneumonia (What is pneumonia?), pyrexia. Neupogen dosage: . During the same period patient was treated with REVLIMID (View Revlimid Review and Revlimid Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), SPIRIVA (View Spiriva Review and Spiriva Label ). Patient was hospitalized.

6596467-3 | Dyspnoea, Metabolic Acidosis, Multi-organ Failure, Pericarditis, Renal Impairment, Septic Shock
Patient was taking Neupogen (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, metabolic acidosis, multi-organ failure, pericarditis, renal impairment, septic shock on Feb 15, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 43 years of age, weighting 194.0 lb, was diagnosed with acute myeloid leukaemia and. Neupogen dosage: . During the same period patient was treated with ARA C (View Ara-c Review and Ara-c Label ), CLOFARABINE (View Clofarabine Review and Clofarabine Label ), FLUDARA (View Fludara Review and Fludara Label ), MYLOTARG (View Mylotarg Review and Mylotarg Label ), IDARUBICIN HCL (View Idarubicin Hcl Review and Idarubicin Hcl Label ), AMBISOME (View Ambisome Review and Ambisome Label ), RASBURICASE (View Rasburicase Review and Rasburicase Label ), VALTREX (View Valtrex Review and Valtrex Label ). Patient was hospitalized.

6593098-6 | Full Blood Count Increased, Splenic Rupture, White Blood Cell Count Increased
Adverse event was reported on Feb 12, 2010 by a Male patient taking Neupogen (View Usage) (Dosage: ) . Location: UNITED STATES , 18 years of age, Patient had the following side effects: full blood count increased, splenic rupture, white blood cell count increased. During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ).

6588047-0 | Autoimmune Thrombocytopenia
on Feb 09, 2010 Male patient from UNITED STATES , weighting 167.6 lb, was diagnosed with peripheral blood stem cell apheresis and was treated with Neupogen (View Usage). After Neupogen was administered, patient had the following side effects: autoimmune thrombocytopenia. Neupogen dosage: .

6581172-X | Abdominal Pain, Bradycardia, Cough, Flushing, Hypersensitivity, Hypotension, Loss Of Consciousness, Nausea, Syncope
on Feb 04, 2010 Female patient from CANADA , weighting 169.8 lb, was treated with Neupogen (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), bradycardia, cough, flushing, hypersensitivity, hypotension, loss of consciousness, nausea (What is nausea?), syncope. Neupogen dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), GRANISETRON (View Granisetron Review and Granisetron Label ). Patient was hospitalized.

6581171-8 | Acute Myeloid Leukaemia, Acute Respiratory Failure, Atrial Fibrillation, Back Pain, Cellulitis, Dizziness, Failure To Thrive, Fall, Full Blood Count Decreased
Patient was taking Neupogen (View Usage). Patient had the following side effects: acute myeloid leukaemia, acute respiratory failure, atrial fibrillation (What is atrial fibrillation?), back pain (What is back pain?), cellulitis (What is cellulitis?), dizziness (What is dizziness?), failure to thrive, fall (What is fall?), full blood count decreased on Feb 04, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 210.1 lb, was diagnosed with myelodysplastic syndrome and. Neupogen dosage: . During the same period patient was treated with PROCRIT (View Procrit Review and Procrit Label ), REVLIMID (View Revlimid Review and Revlimid Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), EFFEXOR (View Effexor Review and Effexor Label ), SINGULAIR (View Singulair Review and Singulair Label ), CITALOPRAM (View Citalopram Review and Citalopram Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), NEXIUM (View Nexium Review and Nexium Label ). Patient was hospitalized.

6575038-9 | Deafness Unilateral, Headache, Leukocytosis, Pain In Extremity
Adverse event was reported on Jan 28, 2010 by a Male patient taking Neupogen (View Usage) (Dosage: ) was diagnosed with blood stem cell harvest and. Location: GERMANY , weighting 211.6 lb, After Neupogen was administered, patient had the following side effects: deafness unilateral, headache (What is headache?), leukocytosis, pain in extremity.

6571778-6 | Bone Pain, Dizziness, Neutrophil Count Decreased, Tinnitus, White Blood Cell Count Decreased
on Jan 27, 2010 Male patient from UNITED STATES , 60 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Neupogen (View Usage). Patient experienced the following unwanted or unexpected effects: bone pain, dizziness (What is dizziness?), neutrophil count decreased, tinnitus (What is tinnitus?), white blood cell count decreased. Neupogen dosage: . During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ), COPEGUS (View Copegus Review and Copegus Label ).

6569750-5 | Abdominal Pain, Bradycardia, Cough, Flushing, Hypersensitivity, Hypotension, Loss Of Consciousness, Nausea, Syncope
on Jan 26, 2010 Female patient from CANADA , weighting 169.8 lb, was treated with Neupogen (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), bradycardia, cough, flushing, hypersensitivity, hypotension, loss of consciousness, nausea (What is nausea?), syncope. Neupogen dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), GRANISETRON (View Granisetron Review and Granisetron Label ). Patient was hospitalized.

6569151-X |
Patient was taking Neupogen (View Usage). on Jan 25, 2010 from UNITED STATES Additional patient health information: Female patient , 49 years of age, was diagnosed with neutropenia and. Neupogen dosage: .

6567630-2 | White Blood Cell Count Decreased
Adverse event was reported on Jan 22, 2010 by a Female patient taking Neupogen (View Usage) (Dosage: ) . Location: GERMANY , 75 years of age, Patient experienced the following unwanted or unexpected effects: white blood cell count decreased. During the same period patient was treated with FLUDARABINE (View Fludarabine Review and Fludarabine Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ).

6554832-4 | Abdominal Pain, Bradycardia, Cough, Flushing, Haematocrit Decreased, Haemoglobin Decreased, Hypersensitivity, Hypotension, Nausea
on Jan 18, 2010 Female patient from CANADA , weighting 169.8 lb, was treated with Neupogen (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), bradycardia, cough, flushing, haematocrit decreased, haemoglobin decreased, hypersensitivity, hypotension, nausea (What is nausea?). Neupogen dosage: . Patient was hospitalized.

6551042-1 | Cholestasis, Jaundice
on Jan 18, 2010 Male patient from FRANCE , weighting 88.18 lb, was diagnosed with infection (What is infection?) and was treated with Neupogen (View Usage). After Neupogen was administered, patient had the following side effects: cholestasis, jaundice (What is jaundice?). Neupogen dosage: . During the same period patient was treated with TAZOCILLINE (View Tazocilline Review and Tazocilline Label ), AMBISOME (View Ambisome Review and Ambisome Label ), FLAGYL (View Flagyl Review and Flagyl Label ), AMIKIN (View Amikin Review and Amikin Label ), TIENAM (View Tienam Review and Tienam Label ), BACTRIM (View Bactrim Review and Bactrim Label ), ZELITREX (View Zelitrex Review and Zelitrex Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ). Patient was hospitalized.

6544132-0 | Interstitial Lung Disease, Pulmonary Fibrosis
Patient was taking Neupogen (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease, pulmonary fibrosis (What is pulmonary fibrosis?) on Jan 15, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 39 years of age, . Neupogen dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ). Patient was hospitalized.

6544127-7 | Autoimmune Thrombocytopenia
Adverse event was reported on Jan 12, 2010 by a Male patient taking Neupogen (View Usage) (Dosage: ) was diagnosed with peripheral blood stem cell apheresis and. Location: UNITED STATES , weighting 167.6 lb, Patient had the following side effects: autoimmune thrombocytopenia.

6543137-3 | Myocardial Infarction
on Jan 12, 2010 Male patient from UNITED KINGDOM , 62 years of age, weighting 224.9 lb, was diagnosed with peripheral blood stem cell apheresis and was treated with Neupogen (View Usage). After Neupogen was administered, patient had the following side effects: myocardial infarction. Neupogen dosage: . During the same period patient was treated with PLERIXAFOR (View Plerixafor Review and Plerixafor Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), OXYNORM (View Oxynorm Review and Oxynorm Label ). Patient was hospitalized.

6532905-X | Arteriospasm Coronary, Platelet Count Decreased
on Jan 07, 2010 Male patient from GERMANY , 34 years of age, weighting 207.2 lb, was diagnosed with blood stem cell harvest and was treated with Neupogen (View Usage). Patient experienced the following unwanted or unexpected effects: arteriospasm coronary, platelet count decreased. Neupogen dosage: . Patient was hospitalized.

6532900-0 | Alopecia, Fatigue, Myalgia, Osteoarthritis, Pain In Extremity
Patient was taking Neupogen (View Usage). Patient had the following side effects: alopecia, fatigue, myalgia, osteoarthritis (What is osteoarthritis?), pain in extremity on Jan 07, 2010 from GERMANY Additional patient health information: Female patient , weighting 167.6 lb, was diagnosed with blood stem cell harvest and. Neupogen dosage: . During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), L THYROXIN (View L-thyroxin Review and L-thyroxin Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ).

6532328-3 | Accidental Overdose, No Adverse Event, White Blood Cell Count Decreased
Adverse event was reported on Jan 04, 2010 by a Female patient taking Neupogen (View Usage) (Dosage: ) . Location: BELGIUM , child 4 years of age, weighting 52.03 lb, After Neupogen was administered, patient had the following side effects: accidental overdose, no adverse event, white blood cell count decreased.

6522596-6 | Anaphylactic Reaction, Flushing, Hypotension, Syncope
on Dec 18, 2009 Female patient from CANADA , 47 years of age, weighting 158.7 lb, was treated with Neupogen (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction, flushing, hypotension, syncope. Neupogen dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), PROCHLORPERAZINE (View Prochlorperazine Review and Prochlorperazine Label ), OXYCET (View Oxycet Review and Oxycet Label ), TYLENOL (CAPLET) (View Tylenol (caplet) Review and Tylenol (caplet) Label ), VALSARTAN (View Valsartan Review and Valsartan Label ).

6522594-2 | Accidental Overdose
on Dec 23, 2009 Female patient from BELGIUM , child 4. years of age, weighting 52.03 lb, was treated with Neupogen (View Usage). Patient had the following side effects: accidental overdose. Neupogen dosage: .

6522529-2 | Accidental Overdose
Patient was taking Neupogen (View Usage). After Neupogen was administered, patient had the following side effects: accidental overdose on Dec 28, 2009 from BELGIUM Additional patient health information: Female patient , child 4. years of age, weighting 52.03 lb, . Neupogen dosage: .

6522514-0 | Blood Creatinine Increased, Haematocrit Decreased, Haemoglobin Decreased, Nausea, Neutrophil Count Decreased, Weight Decreased
Adverse event was reported on Dec 18, 2009 by a Female patient taking Neupogen (View Usage) (Dosage: ) . Location: CANADA , 61 years of age, weighting 116.8 lb, Patient experienced the following unwanted or unexpected effects: blood creatinine increased, haematocrit decreased, haemoglobin decreased, nausea (What is nausea?), neutrophil count decreased, weight decreased. During the same period patient was treated with ASAPHEN (View Asaphen Review and Asaphen Label ), DOCUSATE (View Docusate Review and Docusate Label ), LIPITOR (View Lipitor Review and Lipitor Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), TRIAMIZIDE (View Triamizide Review and Triamizide Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), METFORMIN (View Metformin Review and Metformin Label ).

6522513-9 | Dyspnoea, Hypoaesthesia Oral, Pruritus, Throat Irritation, Tongue Oedema
on Dec 18, 2009 Female patient from CANADA , 42 years of age, weighting 140.2 lb, was treated with Neupogen (View Usage). Patient had the following side effects: dyspnoea, hypoaesthesia oral, pruritus, throat irritation, tongue oedema. Neupogen dosage: . During the same period patient was treated with ATIVAN (View Ativan Review and Ativan Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DECADRON (View Decadron Review and Decadron Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), STEMETIL (View Stemetil Review and Stemetil Label ), ZOFRAN (View Zofran Review and Zofran Label ).

6520325-3 | Bone Pain, Febrile Neutropenia, Headache, Malaise, Pyrexia, Sinusitis, Skin Infection, Urinary Tract Infection
on Dec 15, 2009 Female patient from AUSTRALIA , 26 years of age, was diagnosed with neutropenia and was treated with Neupogen (View Usage). After Neupogen was administered, patient had the following side effects: bone pain, febrile neutropenia, headache (What is headache?), malaise, pyrexia, sinusitis (What is sinusitis?), skin infection, urinary tract infection (What is urinary tract infection?). Neupogen dosage: . During the same period patient was treated with NEULASTA (View Neulasta Review and Neulasta Label ).

6517044-6 | Accidental Overdose
Patient was taking Neupogen (View Usage). Patient experienced the following unwanted or unexpected effects: accidental overdose on Dec 14, 2009 from BELGIUM Additional patient health information: Female patient , child 4. years of age, weighting 52.03 lb, . Neupogen dosage: .

6515904-3 | Neutrophil Count Decreased, White Blood Cell Count Decreased
Adverse event was reported on Nov 26, 2009 by a Female patient taking Neupogen (View Usage) (Dosage: ) . Location: AUSTRALIA , child 6 years of age, weighting 60.19 lb, Patient had the following side effects: neutrophil count decreased, white blood cell count decreased.

6505279-8 | Bone Pain, Cardiovascular Disorder, Haematocrit Decreased, Haemoglobin Decreased, Hypotension, Left Ventricular Failure, Platelet Count Decreased, Pulmonary Oedema
on Dec 10, 2009 Male patient from HUNGARY , weighting 132.3 lb, was treated with Neupogen (View Usage). After Neupogen was administered, patient had the following side effects: bone pain, cardiovascular disorder, haematocrit decreased, haemoglobin decreased, hypotension, left ventricular failure, platelet count decreased, pulmonary oedema. Neupogen dosage: . During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), POTASSIUM (View Potassium Review and Potassium Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), ZANTAC (View Zantac Review and Zantac Label ), MEGESTROL ACETATE (View Megestrol Acetate Review and Megestrol Acetate Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ). Patient was hospitalized.

6505254-3 | Dysfunctional Uterine Bleeding
on Dec 09, 2009 Female patient from UNITED STATES , weighting 156.1 lb, was diagnosed with blood stem cell harvest and was treated with Neupogen (View Usage). Patient experienced the following unwanted or unexpected effects: dysfunctional uterine bleeding. Neupogen dosage: . During the same period patient was treated with VITAMIN D (View Vitamin D Review and Vitamin D Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ).

6483051-5 | Therapeutic Response Decreased
Patient was taking Neupogen (View Usage). Patient had the following side effects: therapeutic response decreased on Nov 30, 2009 from SPAIN Additional patient health information: Male patient , child 5 years of age, was diagnosed with neutropenia and. Neupogen dosage: .